Invention Grant
- Patent Title: Production of recombinant vaccine in E. coli by enzymatic conjugation
-
Application No.: US16034906Application Date: 2018-07-13
-
Publication No.: US10973901B2Publication Date: 2021-04-13
- Inventor: Michael Wacker , Michael Kowarik , Michael Wetter , Amirreza Faridmoayer
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agent Dana L. Broughton
- Main IPC: A61K39/085
- IPC: A61K39/085 ; A61K39/09 ; C12N15/70 ; C12P21/00 ; A61K39/00
Abstract:
Provided herein are prokaryotic cells proficient to produce glycoconjugates in vivo, as well as methods for generating these cell and methods of using these cells to produce glycoconjugates. The compositions of the mentioned glycoconjugates as well as their different uses are also included.
Public/Granted literature
- US20190076517A1 PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION Public/Granted day:2019-03-14
Information query
